Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: HIV Infection
Dose: Tablet – 300 mg
Frequency: every 12 hours
Note: (600 mg/day)
Indication: HIV Infection
Dose: Tablet – 200 mg
Frequency: every 8 hours
Note: (600 mg/day)

Child Dose

Clinical InformationAdministration Information
Indication: HIV Infection, Treatment
Age: 4 weeks-18 years
Dose: Oral – 240 mg/m²
Frequency: every 12 hours
Note: by mouth (oral)
Indication: HIV Infection, Treatment
Age: 4 weeks-18 years
Dose: Oral – 160 mg/m²
Frequency: every 8 hours
Note: by mouth (oral)

Renal Dose

Clinical InformationAdministration Information
Condition: Renal Impairment CrCl less than 15 mL/min (maintained on hemodialysis or peritoneal dialysis)
Dose: Tablet – 100 mg
Frequency: every 6-8 hours
Note: administered by mouth (oral)
Condition: Renal Impairment CrCl less than 15 mL/min (maintained on hemodialysis or peritoneal dialysis)
Dose: Injection – 1 mg/kg
Frequency: every 6-8 hours
Note: administered intravenous
Administration
  • Can be taken with or without food
  • Take exactly as prescribed
Side Effect

Drug Interaction

Drug NameRisk Factors
Tipranavir
Decreased zidovudine concentration
Bortezomib
Increased risk of peripheral neuropathy

Disease Interaction

Disease NameRisk Factors
Abnormally Low Neutrophil Counts
Risk of severe infections
Low Hemoglobin Levels
Risk of severe anemia

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store between 15-25° C.

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.